Alprazolam
Benzodiazepine Derivatives
Sold as Xanax · APO-ALPRAZ · XANAX TS · APO-ALPRAZ TS
- Drug class
- Benzodiazepine Derivatives
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 47
- FDA reports (12 mo)
- 6,407
Overview
Alprazolam is an active pharmaceutical ingredient in the Benzodiazepine Derivatives group (N05BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 25 | May 19, 2026 |
| CA Canada | Health Canada | 18 | January 27, 2026 |
| GB United Kingdom | MHRA | 4 | April 17, 2026 |
USUnited States· FDA
25 products
Uses
1 INDICATIONS AND USAGE Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults.
Alprazolam is a benzodiazepine indicated for the:
Acute treatment of generalized anxiety disorder in adults. ( 1 ) Treatment of panic disorder with or without agoraphobia in adults. ( 1 )
How to take
CACanada· Health Canada
18 products
Uses
AND CLINICAL USE ...................................................................................................................... 3 CONTRAINDICATIONS ...........................................................................................................................................
5 WARNINGS AND PRECAUTIONS .......................................................................................................................... 5 ADVERSE REACTIONS .........................................................................................................................................
13 DRUG INTERACTIONS .......................................................................................................................................... 16 DOSAGE AND ADMINISTRATION ......................................................................................................................
20 OVERDOSAGE ........................................................................................................................................................ 22 ACTION AND CLINICAL PHARMACOLOGY ....................................................................................................
GBUnited Kingdom· MHRA
4 products
Uses
Xanax is indicated for short-term symptomatic treatment of anxiety in adults. Xanax is only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.
How to take
Drug interactions
Known interactions involving Alprazolam. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 02840ea6-e4a0-96… · revised January 3, 2025 [PDF]
- [2]Health Canada (DPD) · 00865397 · revised March 22, 2025
- [3]MHRA (UK) · PL463020328 · revised April 17, 2026
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.